(MedPage Today) -- SILVER SPRING, Md. -- After a long delay, the FDA approved the oral drug alogliptin (Nesina) for treatment of adults with type 2 diabetes, as well as two products combining alogliptin with other antidiabetic drugs. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment